M. B. Sporn, A. B. Roberts, and D. S. Goodman, Retinoids: Biolchemical Education, vol.22, 1993.

R. Blomhoff, Transport and metabolism of vitamin A, Nutr. Rev, vol.52, pp.13-23, 1994.

L. Altucci and H. Gronemeyer, The promise of retinoids to fight against cancer, Nat. Rev. Cancer, vol.1, pp.181-193, 2001.

N. B. Ghyselinck and G. Duester, Retinoic acid signaling pathways. Dev. (Camb. Engl.) 2019, 146
URL : https://hal.archives-ouvertes.fr/hal-02324117

P. Chambon, A decade of molecular biology of retinoic acid receptors, FASEB J, vol.10, pp.940-954, 1996.

P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet, Overview of nomenclature of nuclear receptors, Pharmacol. Rev, vol.58, pp.685-704, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00187929

A. Di-masi, L. Leboffe, E. De-marinis, F. Pagano, L. Cicconi et al., Retinoic acid receptors: From molecular mechanisms to cancer therapy, Mol. Asp. Med, vol.41, pp.1-115, 2015.

H. Gronemeyer, J. A. Gustafsson, and V. Laudet, Principles for modulation of the nuclear receptor superfamily, Nat. Rev. Drug Discov, vol.3, pp.950-964, 2004.

W. Bourguet, V. Vivat, J. M. Wurtz, P. Chambon, H. Gronemeyer et al., Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains, Mol. Cell, vol.5, pp.289-298, 2000.

P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar et al., International Union of Pharmacology. LX. Retinoic acid receptors, Pharmacol. Rev, vol.58, pp.712-725, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00187922

C. Rochette-egly and P. Chambon, F9 embryocarcinoma cells: A cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling, Histol. Histopathol, vol.16, pp.909-922, 2001.

C. Rochette-egly and P. Germain, Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs), Nucl. Recept. Signal, vol.7, p.5, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00420158

E. Moutier, T. Ye, M. A. Choukrallah, S. Urban, J. Osz et al., Retinoic acid receptors recognize the mouse genome through binding elements with diverse spacing and topology, J. Biol. Chem, vol.287, pp.26328-26341, 2012.

A. Chatagnon, P. Veber, V. Morin, J. Bedo, G. Triqueneaux et al., RAR/RXR binding dynamics distinguish pluripotency from differentiation associated cis-regulatory elements, Nucleic. Acids. Res, vol.43, pp.4833-4854, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01170316

L. Nagy, H. Y. Kao, J. D. Love, C. Li, E. Banayo et al., Mechanism of corepressor binding and release from nuclear hormone receptors, Genes Dev, vol.13, pp.3209-3216, 1999.

V. Perissi and M. G. Rosenfeld, Controlling nuclear receptors: The circular logic of cofactor cycles, Nat. Rev. Mol. Cell Biol, vol.6, pp.542-554, 2005.

M. G. Rosenfeld, V. V. Lunyak, and C. K. Glass, Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response, Genes Dev, vol.20, pp.1405-1428, 2006.

J. D. Chen and R. M. Evans, A transcriptional co-repressor that interacts with nuclear hormone receptors, Nature, vol.377, pp.454-457, 1995.

A. J. Horlein, A. M. Naar, T. Heinzel, J. Torchia, B. Gloss et al., Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature, vol.377, pp.397-404, 1995.

M. L. Privalsky, The role of corepressors in transcriptional regulation by nuclear hormone receptors, Annu. Rev. Physiol, vol.66, pp.315-360, 2004.

P. Germain, C. Gaudon, V. Pogenberg, S. Sanglier, A. Van-dorsselaer et al., Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists, Chem. Biol, vol.16, pp.479-489, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00420381

P. Germain, J. Iyer, C. Zechel, and H. Gronemeyer, Coregulator recruitment and the mechanism of retinoic acid receptor synergy, Nature, vol.415, pp.187-192, 2002.

A. Le-maire, C. Teyssier, C. Erb, M. Grimaldi, S. Alvarez et al., A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor, Nat. Struct. Mol. Biol, vol.17, pp.801-843, 2010.

L. Nagy and J. W. Schwabe, Mechanism of the nuclear receptor molecular switch, Trends. Biochem. Sci, vol.29, pp.317-324, 2004.

A. Le-maire and W. Bourguet, Retinoic acid receptors: Structural basis for coregulator interaction and exchange. Sub-Cell Biochem, vol.70, pp.37-54, 2014.

J. P. Renaud, N. Rochel, M. Ruff, V. Vivat, P. Chambon et al., Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid, Nature, vol.378, pp.681-689, 1995.

W. Bourguet, M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras, Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha, Nature, vol.375, pp.377-382, 1995.

N. J. Mckenna and B. W. O'malley, Combinatorial control of gene expression by nuclear receptors and coregulators, Cell, vol.108, pp.465-474, 2002.

E. M. Mcinerney, D. W. Rose, S. E. Flynn, S. Westin, T. M. Mullen et al., Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation, Genes Dev, vol.12, pp.3357-3368, 1998.

S. Westin, R. Kurokawa, R. T. Nolte, G. B. Wisely, E. M. Mcinerney et al., Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators, Nature, vol.395, pp.199-202, 1998.

V. Perissi, L. M. Staszewski, E. M. Mcinerney, R. Kurokawa, A. Krones et al., Molecular determinants of nuclear receptor-corepressor interaction, Genes Dev, vol.13, pp.3198-3208, 1999.

X. Hu and M. A. Lazar, The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors, Nature, vol.402, pp.93-96, 1999.

X. Hu, Y. Li, and M. A. Lazar, Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors, Mol. Cell Biol, vol.21, pp.1747-1758, 2001.

J. Y. Chen, J. Clifford, C. Zusi, J. Starrett, D. Tortolani et al., Two distinct actions of retinoid-receptor ligands, Nature, vol.382, pp.819-822, 1996.

B. Roy, R. Taneja, and P. Chambon, Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand, Mol. Cell Biol, vol.15, pp.6481-6487, 1995.

S. Minucci, M. Leid, R. Toyama, J. P. Saint-jeannet, V. J. Peterson et al., Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression, Mol. Cell Biol, vol.17, pp.644-655, 1997.

E. Nadendla, C. Teyssier, V. Delfosse, V. Vivat, G. Krishnasamy et al., An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor beta (RARbeta, NR1B2) Selective Agonist, PLoS ONE, vol.10, 2015.

R. A. Heyman, D. J. Mangelsdorf, J. A. Dyck, R. B. Stein, G. Eichele et al., 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor, Cell, vol.68, pp.397-406, 1992.

M. B. Sporn, A. B. Roberts, and D. S. Goodman, The Retinoids, pp.1-2, 1984.

L. Altucci, M. D. Leibowitz, K. M. Ogilvie, A. R. De-lera, and H. Gronemeyer, RAR and RXR Modulation in Cancer and Metabolic Disease, Nat. Rev. Drug Disc, vol.6, pp.793-810, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00192059

R. Alvarez, B. Vaz, H. Gronemeyer, and A. R. De-lera, Functions, therapeutic applications, and synthesis of retinoids and carotenoids, Chem. Rev, vol.114, pp.1-125, 2014.

S. Nagpal and R. A. Chandraratna, Recent Developments in Receptor-Selective Retinoids, Curr. Pharm. Des, vol.6, pp.919-931, 2000.

M. I. Dawson, Synthetic retinoids and their nuclear receptors, Curr. Med. Chem. Anticancer Agents, vol.4, pp.199-230, 2004.

H. Kagechika and K. Shudo, Synthetic retinoids: Recent developments concerning structure and clinical utility, J. Med. Chem, vol.48, pp.5875-5883, 2005.

M. Gehin, V. Vivat, J. M. Wurtz, R. Losson, P. Chambon et al., Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists, Chem. Biol, vol.6, pp.519-529, 1999.

A. R. De-lera, W. Bourguet, L. Altucci, and H. Gronemeyer, Design of selective nuclear receptor modulators: RAR and RXR as a case study, Nat. Rev. Drug Discov, vol.6, pp.811-820, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00188872

J. Y. Chen, S. Penco, J. Ostrowski, P. Balaguer, M. Pons et al., RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation, EMBO J, vol.14, pp.1187-1197, 1995.

E. S. Klein, M. E. Pino, A. T. Johnson, P. J. Davies, S. Nagpal et al., Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists, J. Biol. Chem, vol.271, pp.22692-22696, 1996.

C. Koch, S. S. Dardashti, L. J. Hebert, J. J. White, S. K. Croston et al., Identification of the First Retinoid X Receptor Homodimer Antagonist, J. Med. Chem, vol.39, pp.3229-3234, 1996.

D. S. Lala, R. Mukherjee, I. G. Shulman, S. S. Koch, L. J. Dardashti et al., Activation of specific RXR heterodimers by an agonist of RXR homodimers, Nature, vol.383, pp.450-453, 1996.

I. G. Schulman, C. Li, J. W. Schwabe, and R. M. Evans, The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor, Genes Dev, vol.11, pp.299-308, 1997.

S. Nagpal, S. Friant, H. Nakshatri, and P. Chambon, RARs and RXRs: Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo, EMBO J, vol.12, pp.2349-2360, 1993.

P. Germain, S. Kammerer, E. Perez, C. Peluso-iltis, D. Tortolani et al., Rational design of RAR-selective ligands revealed by RARbeta crystal stucture, EMBO Rep, vol.5, pp.877-882, 2004.

V. Nahoum, E. Perez, P. Germain, F. Rodriguez-barrios, F. Manzo et al., Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function, Proc. Natl. Acad. Sci, vol.104, pp.17323-17328, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00188372

P. Balaguer, A. M. Boussioux, E. Demirpence, and J. C. Nicolas, Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands, Luminescence, vol.16, pp.153-158, 2001.

V. Vivat, C. Zechel, J. M. Wurtz, W. Bourguet, H. Kagechika et al., A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers, EMBO J, vol.16, pp.5697-5709, 1997.

A. G. Leslie, The integration of macromolecular diffraction data, Acta. Cryst. D Biol. Cryst, vol.62, pp.48-57, 2006.

, The CCP4 suite: Programs for protein crystallography, Acta Cryst. D Biol. Cryst, vol.50, pp.760-763, 1994.

A. Le-maire, M. Grimaldi, D. Roecklin, S. Dagnino, V. Vivat-hannah et al., Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors, EMBO Rep, vol.10, pp.367-373, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00375675

P. Emsley and K. Cowtan, Coot: Model-building tools for molecular graphics, Acta Cryst. D Biol. Cryst, vol.60, pp.2126-2132, 2004.

Z. Szondy, U. Reichert, J. M. Bernardon, S. Michel, R. Toth et al., Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway, Mol. Pharmacol, vol.51, pp.972-982, 1997.

C. Apfel, F. Bauer, M. Crettaz, L. Forni, M. Kamber et al., A retinoic acid receptor a antagonist selectively counteracts retinoic acid effects, Proc. Natl. Acad. Sci, vol.89, pp.7129-7133, 1994.

S. Toma, L. Isnardi, P. Raffo, L. Riccardi, G. Dastoli et al., RARalpha antagonist Ro 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines, Int. J. Cancer, vol.78, pp.86-94, 1998.

M. I. Dawson, W. R. Chao, P. Pine, L. Jong, P. D. Hobbs et al., Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells, Cancer Res, vol.55, pp.4446-4451, 1995.

A. Joyeux, P. Balaguer, P. Germain, A. M. Boussioux, M. Pons et al., Engineered cell lines as a tool for monitoring biological activity of hormone analogs, Anal. Biochem, vol.249, pp.119-130, 1997.

M. Schupp, J. C. Curtin, R. J. Kim, A. N. Billin, and M. A. Lazar, A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity, Mol. Pharmacol, vol.71, pp.1251-1257, 2007.

J. F. Boylan, D. Lohnes, R. Taneja, P. Chambon, and L. J. Gudas, Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment, Proc. Natl. Acad. Sci, vol.90, pp.9601-9605, 1993.

E. Perez-santin, P. Germain, F. Quillard, H. Khanwalkar, F. Rodriguez-barrios et al., -tetrahydronaphthalen-2-y l)phenyl]acrylic acids and their 4-alkoxy isomers, J. Med. Chem, vol.7, issue.8, pp.3150-3158, 2009.

Y. Sato, N. Ramalanjaona, T. Huet, N. Potier, J. Osz et al., Phantom Effect" of the Rexinoid LG100754: Structural and functional insights, PLoS ONE, vol.5, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00561386

P. F. Egea, A. Mitschler, N. Rochel, M. Ruff, P. Chambon et al., Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid, EMBO J, vol.19, pp.2592-2601, 2000.

V. Pogenberg, J. F. Guichou, V. Vivat-hannah, S. Kammerer, E. Perez et al., Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies, J. Biol. Chem, vol.280, pp.1625-1633, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00187727

D. A. Mangelsdorf and R. M. Evans, The RXR Heterodimers and Orphan Receptors, Cell, vol.83, pp.841-850, 1995.

F. Rastinjead, Retinoid X receptor and its partners in the nuclear receptor family, Curr. Op. Struc. Biol, vol.11, pp.33-38, 2001.

A. I. Shulman and D. J. Mangelsdorf, Retinoid x receptor heterodimers in the metabolic syndrome, New Engl. J. Med, vol.353, pp.604-615, 2005.

P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar et al., The pharmacology and classification of the nuclear receptor superfamily. RETINOID X RECEPTORS (RXRs), Pharmacol. Rev, vol.58, pp.760-772, 2006.

R. M. Evans and D. J. Mangelsdorf, Nuclear Receptors, RXR, and the Big Bang, Cell, vol.157, pp.255-266, 2014.

I. G. Schulman, H. Juguilon, and R. M. Evans, Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states, Mol. Cell Biol, vol.16, pp.3807-3813, 1996.

M. A. Mendoza-parra, M. Walia, M. Sankar, and H. Gronemeyer, Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics, Mol. Syst. Biol, 2011.

T. N. Cordeiro, N. Sibille, P. Germain, P. Barthe, A. Boulahtouf et al., Interplay of Protein Disorder in Retinoic Acid Receptor Heterodimer and Its Corepressor Regulates Gene Expression, Structure, vol.27, pp.1270-1285, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02268989

C. Agarwal, R. A. Chandraratna, A. T. Johnson, E. A. Rorke, and R. L. Eckert, AGN193109 Is a Highly Effective Antagonist of Retinoid Action in Human Ectocervical Epithelial Cells, J. Biol. Chem, vol.271, pp.12209-12212, 1996.

J. Botling, D. S. Castro, F. Oberg, K. Nilsson, and T. Perlmann, Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation, J. Biol. Chem, vol.272, pp.9443-9449, 1997.

Y. Li, Y. Hashimoto, A. Agadir, H. Kagechika, and X. Zhang, Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells, J. Biol. Chem, vol.274, pp.15360-15366, 1999.